1622.8000 -12.10 (-0.74%)
NSE Sep 24, 2025 15:29 PM
Volume: 101.4K
 

1622.80
-0.74%
Motilal Oswal
Eris Lifesciences (ERIS) posted lower-than-expected 4QFY25 performance. This has been largely due to a marginal slip in the execution, particularly in the insulin revenue.
Eris Lifesciences Ltd. has an average target of 1581.00 from 3 brokers.
More from Eris Lifesciences Ltd.
Recommended